Objective. Stiffness is internationally recognized as an important indicator of inflammatory activity in RA but is poorly understood and difficult to measure. The aim of this study was to explore the experience of stiffness from the patient perspective.
Introduction
RA is a chronic, systemic, inflammatory condition causing synovitis and resulting in pain, swelling and stiffness [1] . Morning stiffness (MS) is included in the original ACR classification of RA and remission criteria [2, 3] . Early MS (EMS) is considered an indicator of inflammatory activity and rheumatologists use stiffness as a crucial variable in decision-making for changing medication [4, 5] . MS is also widely used in RA research, particularly pharmacological trials [6] , and is a key outcome in current research into timed-release glucocorticoid treatments [7, 8] . Stiffness in the inflammatory process is thought to be related to increases in pro-inflammatory cytokines such as IL-6 [9, 10] .
Clinically, stiffness is frequently reported by patients [11, 12] and has considerable effects on daily life, work and quality of life [1315] . However, these studies have generally focused on morning function, making it difficult to differentiate stiffness from pain and disability. In qualitative research by the OMERACT Flare Working Group, patients considered MS to be an important influence on decisions to seek medication review [16] . In the resultant combined international patient and professional Delphi exercise, stiffness was prioritized as a potential item for a core set of flare measures (79% consensus) [17] . Furthermore, in a recent qualitative study, patients highlighted stiffness reduction as a crucial aspect of RA remission [18] .
Traditionally, assessment is through questions about EMS duration or severity. However, different question formats [visual analogue scales (VASs), numerical rating scales, Likert scales] for severity are not interchangeable and severity does not correlate with duration [19] . Patients who answer no to the presence of EMS have later reported its duration in minutes in a subsequent question, implying the questions are unclear [12] . Given these measurement difficulties, it is vital to understand the concept of stiffness from the patient perspective if we are to evaluate it effectively. Only one study has focussed on understanding the patient experience of stiffness [20] , but it was conducted more than a decade ago, since when there have been substantial changes in RA treatment [21] and thus likely changes in stiffness experience. Furthermore, no validated stiffness measure has been developed using the recommended methodology including concept mapping through qualitative exploration [22] . Therefore the aim of this study was to explore the experiences of stiffness in patients with RA.
Patients and methods

Following ethics approval (Leeds East Research Ethics
Committee, 13/YH00/50) patients with confirmed RA [2] and experience of RA-related stiffness were invited to participate in semi-structured interviews. Patients attending outpatient clinics at two National Health Service (NHS) trusts were purposefully sampled using a sampling frame to reflect a range of age, gender and disease duration.
An interview guide (Table 1) was developed based on a literature review and discussion with the research team ( Table 2 ). Interviews and analysis followed an iterative process that allowed ideas and concepts identified in early analysis to be explored in subsequent interviews [23] . All patients gave informed consent and completed a disability questionnaire (HAQ) [24] , perceived disease activity VAS [25] and pain VAS. All interviews were conducted by one researcher (S. Halls) who was unknown to participants prior to the study and introduced herself as a non-clinical researcher. Interviews were conducted with only the researcher and participant present except for one interview where the participant brought her young son. Interviews took place in non-clinical rooms, lasted between 30 and 80 min, were audio-recorded and then transcribed verbatim. Data collection continued until saturation was reached and no new themes were emerging.
Data were analysed using inductive thematic analysis, a method of identifying and reporting patterns in data without the use of an a priori model [26] . Data were managed using NVivo 10 (QSR International, Doncaster, VC, Australia) [27] and Microsoft Office Word 2007. Transcripts were read, re-read and systematically coded, then codes were explored for patterns, which led to theme development [26] . The interviewer (S. Halls) analysed all transcripts. Researchers (S. Hewlett, E.D.) independently analysed two transcripts, patient research partners [28] (G.B., A.E.), after a brief introduction, also read two transcripts and highlighted relevant points from their perspective, and discussions among the research team throughout the analysis process facilitated agreement on the developing codes and themes.
Results
Sixteen of 38 patients who were approached agreed to participate (42%): 11 female, aged 3378 years, disease duration 127 years (Table 3) . Analysis identified 219 Relationships with other RA symptoms were apparent, most significantly between pain and stiffness, which was stronger during flares: I think they are separate but when, you know, when everything's sore, everything's swollen and everything's stiff, it's all kind of you know, in a bag together and then you're just in a pickle really. Although some found it difficult to differentiate, most patients could discuss pain and stiffness independently and felt they were different yet related concepts: 'They're connected and related but they're not interdependent [. It is a bit random, it does tend to move around, I might be sort of 6 months with it really bad in my feet and my knees and then I might find that it is worse in my back and hips and then it might move up to my shoulders and my elbows. (Patient 102) For some patients, stiffness was described as being more of a whole-body experience, particularly during the morning or flare: '. . . stiffness when you're getting up, it feels like all up your arms and your legs and your whole body more' (Patient 116).
Theme 3: Linked to behaviour and environment While patients related stiffness to their disease, they also associated it with their behaviour and environment. Stiffness was considered a result of both immobility: 'Oh it's always much more difficult to get up after sitting still' (Patient 103) and overactivity: '. . . if I have had a busy day, and I haven't been able to rest [. . .] then I might find that it is creeping back in the evening as well' (Patient 102).
Medications were perceived to influence the duration, severity and impact of stiffness: '. . . Patients sometimes felt that the dramatic effect of medication on stiffness was ignored due to the lack of an appropriate assessment method:
I kind of feel that it's sort of a lost entity because actually the drug is working, one of the things that they've really transformed has been my stiffness, but it's never been a measure that's kind of been considered [. . .] the one thing they've never asked me about is joint stiffness and the one thing I'm absolutely delighted about is that I can now get up and get him [my son] up whereas I haven't for two and a half years because I can't do that in the morning [. Just everything I think when you get a flare and it's really bad. Again it's just your hands just don't work basically. They can't bend them, grip things, and obviously it's really painful and it makes everything awkward. When they are not so bad you can do basic stuff, you can pick up a kettle, you can do bits and bobs. There is a big difference between the two. (Patient 115) Stiffness was also perceived to recur more frequently, including at night, and affect more joints: '. . . it's not just on a morning it's all throughout the night . . .' (Patient 113).
Theme 5: impacts on daily life
Patients evaluated their stiffness in terms of its impact rather than duration and severity. Physical function was considerably influenced by stiffness, including reduced mobility, balance, dexterity, grip and range and speed of movement: 'Just, I mean a job to move really, your limbs and your joints, your fingers. You can move them but they just, I just find it sometimes initially quite hard to do . . .' Stiffness was highlighted as impacting on quality of life, and disruption of normality was stressed, as was impact on ability to work: 'I am not safe enough to be on a building site I don't think, I couldn't get up steps and stuff, things that I used to do' (Patient 102). Some patients experienced an improved ability to cope with stiffness as a result of retirement:
. . . getting up to go to work was getting worse because it was taking longer to be able to get to move to be able to put the car in gear [. For one, the only effective management was a steroid injection: 'So that's extreme stiffness, and I am not exaggerating that [. . .] it seems the only way to resolve that one is to have a massive injection of steroid' (Patient 101).
Discussion
Patients experience stiffness as significant, variable and complex. Stiffness was reported to be a normal part of having RA, experienced in joints and more widespread, related to behavioural and environmental factors and to have marked variability (including not being limited to early morning). It resulted in wide-ranging consequences that had a major impact on patient's daily lives and necessitated self-management.
Patients placed greater importance on stiffness impact than stiffness severity or duration. While impact was mentioned in earlier research [20] , patient-reported outcome measures (PROMs) have continued to rely on nonstandardized, unvalidated duration and severity questions. Although stiffness duration is most frequently assessed in trials [12] , stiffness severity has been reported to have stronger correlations with relevant outcomes and inflammatory markers [29] . Severity and duration do not correlate [19] and a recent review of stiffness in lowdisease states [30] shows the only two PROM validation studies make conflicting recommendations on whether severity or duration is best [29, 31] . It is therefore time to consider the potential effectiveness of measuring stiffness via concepts beyond severity and duration. The most compelling argument is for the impact of stiffness, which was how patients in this study defined and evaluated stiffness. This would fit with the impact triad, which recommends considering not only the severity of an outcome, but also its importance to patients and their ability to self-manage it [32] .
These patient perspectives on stiffness might explain the poor performance of traditional stiffness questions. Duration questions generally ask about EMS using various baselines, including from awakening or from getting up, and various endpoints, including start of improvement, substantial improvement or complete resolution [31] . Importantly, patients in this study did not relate stiffness exclusively to early morning, which could explain their difficulty in trying to determine a start or end point. In addition, traditional simple questions assume (but do not specify) that patients evaluate stiffness related to inflammatory processes, yet patients in this study could identify differences in inflammatory and mechanical stiffness. Finally, in existing assessment there is no consideration of stiffness location, yet patients report stiffness in single and multiple joints, as well as widespread (non-joint) stiffness, which they consider more severe. In moving forward to the development of individual items for inclusion in an appropriate RA stiffness PROM, aspects such as these should be captured to enhance the clarity of the target concept [33, 34] .
While this study included only 16 participants from two NHS trusts in the same city, the sample included a range of ages, gender, treatment regimens and disease durations. There may be cross-cultural differences in the perception of stiffness, which is an area for further research. Furthermore, data saturation was achieved [35] . A key strength of the study included the reliability of the findings through independent analysis by other members of the research team [36] .
These data provide important information about a wellrecognized symptom that has a major impact on patients' daily lives and that is used internationally both clinically and in research. Stiffness measurement to date is not standardized, is unvalidated, inconsistent and unreliable and has not been developed according to current standards including collaboration with patients [33, 34, 37] . The importance of collaboration was demonstrated in fatigue, where collaboration led to international consensus that it should be assessed in addition to the core set in RA trials and development of the Bristol RA Fatigue scales [3841] . This current study has demonstrated the importance of stiffness to patients, including one patient who reported that the significant impact of her medications went unrecognized due to lack of an appropriate stiffness measure. Further research now needs to use these data to develop potential items for a stiffness PROM. Development and validation of a stiffness PROM will open up the potential for stiffness to be included in the ACR disease activity core set (currently omitted because it cannot be measured with sensitivity or specificity) [42] . It would also address the OMERACT 2010 research agenda item for development of a stiffness PROM in relation to flare [43] .
Rheumatology key messages
. For patients with RA who experience it, stiffness is an important and complex symptom. . Patients with RA generally characterize and define stiffness by its impact rather than duration or severity. . These data have implications for the development of an appropriate RA stiffness patient-reported outcome measure.
